Theranostics is considered as a fusion of diagnostics and drug therapy. It helps in optimizing safety, effective results, and streamlining of overall drug development. The combination of advanced diagnostic tests and effective medical drugs has been given several names, such as pharmacodiagnostics, integrated medicine, Dx/Rx partnering, and companion diagnostics. Research activities in this field are contributing extensively ... Read more
The global theranostics market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for theranostics are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the theranostics market that is critical for defining your ... Read more
Theranostics is a new field of medicine which combines therapeutics, nanoscience, and diagnostics based on specific targeted diagnostic tests. Theranostics is also called as theragnostics or companion diagnostics (CDx), or pharmacodiagnostics or personalized medical care, or personalized therapy, or personalized medicine technology. The Global Theranostics Market Size accounted for USD 7,968. ... Read more
Global Theranostics Market Share Research Report: Information by Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Disorders, Immunological Disorders and others), Technology [Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Sequencing, Others], End User (Hospitals and Clinics, Diagnostic Laboratories, Others) and Region - Forecast till 2025
